Global Sennosides Market Size, Share, and COVID-19 Impact Analysis, By Product (Sennosides A and Sennosides B), By Application (Pharmaceutical Industry and Food Industry, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033

Global Sennosides Market Insights Forecasts to 2033

• The Global Sennosides Market Size was Estimated at USD 375.69 Million in 2023
• The Market Size is Expected to Grow at a CAGR of around 4.02% from 2023 to 2033
• The Worldwide Sennosides Market Size is Expected to reach USD 557.45 Million by 2033
• Asia Pacific is predicted to Grow at the fastest CAGR throughout the projection period

The Global Sennosides Market Size is predicted to Exceed USD 557.45 Million by 2033, Growing at a CAGR of 4.02% from 2023 to 2033.

Market Overview

The market for sennosides, which mainly focuses on natural laxatives made from senna leaves and pods, is driven by digestive issues, the use of herbal medicine in healthcare, and growing consumer preference for plant-based therapeutic options. Sennosides are stimulant laxatives that are used to alleviate constipation and cleanse the intestines before bowel examinations or procedures. They are found in Cassia angustifolia and Cassia senna. They cause movement in the intestines by retaining water inside. The plant-based laxative senna, which contains the anthroquinone glucosides sennoside A and sennoside B, has a mild purgative effect and irritates the lining of the colon. Intestinal bacteria break down senna to produce potent anthraquinone derivatives. The rising incidence of constipation in the general population is driving a substantial expansion in the worldwide sennosides market. In order to introduce new products, such as sennosides plant-based laxatives that contain the anthraquinone glucosides sennoside A and sennoside B key players are concentrating on research and development. The research and launch of these pharmaceuticals are being driven by the growing demand for these medications, especially among pregnant women. The popularity of herbal supplements is being driven by consumers' desire for them due to their advantages, which include better health and fewer negative effects.

The increasing prevalence of the constipation accelerates the need for the herbal supplements such senna laxatives which escalates the demand for the sennosides and leading to the market expansion. For instance, the data provided by the Constipation is a prevalent gastrointestinal disorder in older adults and children, with 29.6% prevalence worldwide. It accounts for 3% to 5% of pediatric visits in the US and high healthcare costs. Up to 84% of functionally constipated children experience faecal incontinence and behavioral issues.

Report Coverage

This research report categorizes the global sennosides market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global sennosides market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global sennosides market.

Driving Factors:

The market for sennosides is fueled by consumer demand for clean-label products, regulatory support for botanical ingredients in healthcare products, growing applications in pharmaceuticals, dietary supplements, functional foods, and cosmetics, growing awareness of digestive health, and growing preference for natural and plant-based products. Given the rising demand for natural solutions to digestive issues, the market expansion is especially advantageous in wellness-focused segments. Demand can be further increased by product improvements and packaging that emphasize Sennosides' natural, side-effect-free qualities.

Restraining Factors

The stringent regulatory regulations, the presence of alternative laxatives, and synthetic laxative drugs, consumption of sennosides for a long period may lead to several potential side effects such as stomach cramps, stomach discomfort, limited awareness of the constipation, and medications may impede the market expansion.

Market Segmentation

The global sennosides market share is classified into product and application.

• The sennosides A segment dominated the global sennosides market in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the product, the global sennosides market is categorized into sennosides A and sennosides B. Among these, the sennosides A segment dominated the global sennosides market in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segmental expansion is attributed to the increasing cases of constipation, growing use of natural and herbal therapeutic products, reduced risk of systemic constipation, and extensive usage of sennosides A in the treatment of inflammatory conditions, diabetes, viral infections, and oxidative stress.

• The pharmaceutical industry segment accounted for the largest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the application, the global sennosides market is categorized into the pharmaceutical industry, food industry, and others. Among these, the pharmaceutical industry segment accounted for the largest market share in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The sector dominance is accelerated by the following factors, such as increasing need for herbal medicine, growing use of sennosides as natural laxatives, increasing number of regulatory approvals, and rising cases of digestive problems globally.

Regional Segment Analysis of the Global Sennosides Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global sennosides market over the predicted timeframe. 

North America is anticipated to hold the largest share of the global sennosides market over the predicted timeframe. The US and Canada lead the North American sennoside market, attributed to the rising popularity of herbal remedies, over-the-counter laxatives, and awareness of gut health. Government backing for botanical supplements, consumer trust in plant-based healthcare products, and the use of herbal ingredients in medicines all have an impact on the market. While the dietary supplement sector and regulatory approvals support market expansion, major pharmaceutical companies are spearheading innovation and diversity in the product field.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. The increased use of herbal remedies, traditional medicine, and health-conscious consumer trends are all driving the growth of the Asia-Pacific sennosides market. Sennoside-based products are growing progressively in nations like China, India, Japan, and South Korea. The market is further being driven by government programs that support traditional Chinese medicine and Ayurveda. Growth is additionally being driven by the need for dietary supplements and natural laxatives, as well as a focus on digestive health.  Manufacturers are concentrating on innovation, sustainable sourcing, and diversifying their product lines to meet changing consumer needs. The market is anticipated to expand as a result of ongoing research and regulatory assistance throughout the projected timeframe.

Europe is projected to hold a significant share of the global sennosides market throughout the projected timeframe. The market for sennosides is dominated by Germany, the UK, France, and Italy, and has significantly increased in Europe due to the demand for herbal and natural health products. Rising consumer awareness, governmental legislation, and investments in medications derived from plants are all responsible for this growth. Market expansion is being propelled by the region's emphasis on alternative medicine, preventive healthcare, and functional foods that contain substances beneficial to digestive health. Important participants, including well-known producers of herbal medicines and research centers, are launching cutting-edge products to satisfy this need.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global sennosides market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Manx Healthcare
• Patel Phyto Extractions Pvt. Ltd.
• Himalaya Wellness Company
• Aviro Health L.P.
• Globela Pharma Pvt. Ltd.
• Swanson Health Products
• Herbalife Nutrition Ltd.
• NOW Foods
• Nature’s Way
• Alchem International Pvt. Ltd.
• Shashi Phytochemical
• Boyd Pharmaceuticals Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In March 2021, Avrio Health L.P., a subsidiary of Purdue Pharma L.P., developed the two Senokot Dietary Supplement products: Senokot Laxative, Gummies (Blueberry Pomegranate Flavor), and Senokot Laxative (Tea). These products are used for relief from occasional constipation.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global sennosides market based on the below-mentioned segments:

Global Sennosides Market, By Product

• Sennosides A
• Sennosides B

Global Sennosides Market, By Application

• Pharmaceutical Industry
• Food Industry
• Others

Global Sennosides Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa